April 22 - 26, 2024
Seattle, Washington
May 7 - 9, 2024 (Virtual)
Symposium Supporters
2024 MRS Spring Meeting
SB01.02.03

Remote Stimuli-Responsive Nanomaterials for Regenerative and Cancer Therapy

When and Where

Apr 23, 2024
2:15pm - 2:30pm
Room 428, Level 4, Summit

Presenter(s)

Co-Author(s)

Heemin Kang1,Yuri Kim1,Hyunsik Hong1,Nayeon Kang1,Sungkyu Lee1,Sunhong Min1

Korea University1

Abstract

Heemin Kang1,Yuri Kim1,Hyunsik Hong1,Nayeon Kang1,Sungkyu Lee1,Sunhong Min1

Korea University1
Cells constantly interact with native nanostructured extracellular matrix at the molecular level. Nanomaterials responsive to tissue-penetrative remote stimuli can be designed to present bioactive ligands or deliver functional molecules as a nanomedicine to regulate or elucidate dynamic nanoscale cell-material interactions. In this talk, I will demonstrate the design of dynamic nanomaterials that can be remotely and spatiotemporally controlled via various remote stimuli, such as magnetic field, light, self-assembling molecules, or their combinations.<br/><br/>In particular, I will show that magnetic field can control the motion of magnetic nanomaterials, such as reversibly controlling RGD ligand nano-coupling, nano-blocking, nano-stretching, and nano-interconnectivity with graph theory-based analysis, which can regulate the focal adhesion-mediated mechanotransduction and resultant differentiation of stem cells. Near-infrared light can activate photonic nanomaterials to trigger photoisomerization, thereby mediating the swelling of liganded supramolecular self-assembly, which can be reversibly deswelled by visible light. Such photonic control enables <i>in vivo</i> stability imaging and spatiotemporally controlled molecular delivery to regulate the adhesion-dependent pro-inflammatory vs. pro-regenerative polarization of macrophages. Furthermore, molecules and ions can reversibly induce <i>in situ</i> self-assembly of biofunctional nanomaterials.<br/><br/>I will also introduce a couple of representative examples of recent cancer therapies and diagnostic imaging controllable by remote stimuli, such as magnetic field, light, and ultrasound, which utilize mechanical force, 1-D nanomaterials, in situ self-assembly, ferroptosis, and others. These strategies can present benefits for safe personalized precision therapies while minimizing drug resistance and side effects.

Keywords

self-assembly

Symposium Organizers

Weibo Cai, University of Wisconsin--Madison
Bella Manshian, KU Leuven
Dalong Ni, Shanghai Jiao Tong University.
Ruirui Qiao, The University of Queensland

Symposium Support

Bronze
EXODUS BIO
JINAN NANOMEDICINE (HONG KONG) CO., LIMITED
Journal of Nanobiotechnology
KeAi-Bioactive Materials
POP Biotechnologies
Portrai Inc.
Promega Corporation
RAYSOLUTION Healthcare Co., Ltd
Shandong Madic Technology Co., Ltd.
United Well Technologies (China) Limited

Session Chairs

Ruirui Qiao
Hao Song

In this Session